UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003937
Receipt number R000004736
Scientific Title Prospective Multi-institutional Observation Study of Charged Particle Radiation Therapy for Patients with Prostate Cancer
Date of disclosure of the study information 2010/08/01
Last modified on 2016/11/01 14:07:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Multi-institutional Observation Study of Charged Particle Radiation Therapy for Patients with Prostate Cancer

Acronym

Multi-institutional Study of Charged Particle Radiation Therapy for Prostate Cancer

Scientific Title

Prospective Multi-institutional Observation Study of Charged Particle Radiation Therapy for Patients with Prostate Cancer

Scientific Title:Acronym

Multi-institutional Study of Charged Particle Radiation Therapy for Prostate Cancer

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of charged particle (carbon ion and proton) radiotherapy for prostate cancer, by common protocol among multiple institutions

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

relapse-free survival rate

Key secondary outcomes

overall survival rate
incidence of radiation toxicity
quality of life


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1)pathologically confirmed prostate cancer
2)previously untreated or receiving hormone therapy within 12 months and possible to record sufficient medical informations for analysis
3)clinical stage T1-T3N0M0
4)written informed consent

Key exclusion criteria

1)re-elevation of serum prostate specific antigen (PSA) after start of hormone therapy
2)impossible to refer pathological specimen
3)active concurrent malignancy
4)other medical or psychological reasons for exclusion

Target sample size

656


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tadashi Kamada

Organization

National Institute of Radiological Sciences

Division name

Research Center for Charged Particle Therapy

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba 263-8555

TEL

043-206-3350

Email

kamada.tadashi@qst.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Tsuji

Organization

National Institute of Radiological Sciences

Division name

Research Center for Charged Particle Therapy

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba 263-8555

TEL

043-206-3350

Homepage URL


Email

h_tsuji@nirs.go.jp


Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

Japanese Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

放射線医学総合研究所(千葉県)、群馬大学(群馬県)、国立がんセンター東病院(千葉県)、静岡がんセンター(静岡県)、兵庫県粒子線医療センター(兵庫県)、筑波大学(茨城県)、若狭湾エネルギー研究センター(福井県)、南東北病院(福島県)


Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date

2018 Year 07 Month 01 Day

Date of closure to data entry

2018 Year 07 Month 01 Day

Date trial data considered complete

2018 Year 07 Month 01 Day

Date analysis concluded

2019 Year 03 Month 01 Day


Other

Other related information

Comparative analysis with results of historically or simultaneously performed studies of X-ray radiotherapy, brachytherapy, or surgery will be carried out.
In addition, comparative analysis between carbon ion and proton will be performed.


Management information

Registered date

2010 Year 07 Month 22 Day

Last modified on

2016 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004736


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name